Mark E. Issa

719 total citations
18 papers, 532 citations indexed

About

Mark E. Issa is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Mark E. Issa has authored 18 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Mark E. Issa's work include Histone Deacetylase Inhibitors Research (4 papers), Cancer Mechanisms and Therapy (3 papers) and Immune Cell Function and Interaction (3 papers). Mark E. Issa is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Cancer Mechanisms and Therapy (3 papers) and Immune Cell Function and Interaction (3 papers). Mark E. Issa collaborates with scholars based in Canada, Switzerland and United States. Mark E. Issa's co-authors include Kerry B. Goralski, Matthew C. Ernst, Christopher J. Sinal, Muriel Cuendet, Wim Vanden Berghe, Chandra Sekhar Chirumamilla, Claudina Pérez-Novo, Gilles Carpentier, Sarah Berndt and John M. Pezzuto and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Endocrinology.

In The Last Decade

Mark E. Issa

18 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Issa Canada 11 224 189 115 84 60 18 532
Xiaowei Ma China 11 249 1.1× 124 0.7× 114 1.0× 33 0.4× 15 0.3× 24 606
Tian Shen China 12 342 1.5× 79 0.4× 114 1.0× 44 0.5× 52 0.9× 33 610
Lingling Xuan China 17 263 1.2× 117 0.6× 97 0.8× 46 0.5× 20 0.3× 37 607
Alexander T. Sougiannis United States 9 163 0.7× 105 0.6× 138 1.2× 62 0.7× 29 0.5× 13 400
Areej Al-Roub Kuwait 11 154 0.7× 122 0.6× 88 0.8× 67 0.8× 19 0.3× 16 452
Jung Hwan Yu South Korea 18 229 1.0× 407 2.2× 136 1.2× 47 0.6× 28 0.5× 42 800
Zhiyuan Chen China 11 302 1.3× 137 0.7× 143 1.2× 42 0.5× 26 0.4× 23 646
Eun Suk Ha South Korea 9 299 1.3× 69 0.4× 78 0.7× 42 0.5× 21 0.3× 11 512
Shenglong Zhu China 15 406 1.8× 160 0.8× 101 0.9× 48 0.6× 17 0.3× 52 706
Samira Asghari Iran 10 289 1.3× 48 0.3× 77 0.7× 49 0.6× 25 0.4× 18 517

Countries citing papers authored by Mark E. Issa

Since Specialization
Citations

This map shows the geographic impact of Mark E. Issa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Issa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Issa more than expected).

Fields of papers citing papers by Mark E. Issa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Issa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Issa. The network helps show where Mark E. Issa may publish in the future.

Co-authorship network of co-authors of Mark E. Issa

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Issa. A scholar is included among the top collaborators of Mark E. Issa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Issa. Mark E. Issa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Schcolnik‐Cabrera, Alejandro, et al.. (2024). Glioblastoma stem cell metabolism and immunity. Cancer and Metastasis Reviews. 43(3). 1015–1035. 10 indexed citations
2.
Issa, Mark E., et al.. (2023). Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections. Frontiers in Oncology. 13. 1251355–1251355. 3 indexed citations
3.
Issa, Mark E. & Christopher E. Rudd. (2021). Glycogen Synthase Kinase-3 (GSK-3) Regulation of Inhibitory Coreceptor Expression in T-cell Immunity. PubMed. 3(5). 336–342. 4 indexed citations
4.
Krueger, Janna, et al.. (2021). Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy. PLoS ONE. 16(6). e0251731–e0251731. 13 indexed citations
5.
Wijeratne, E. M. Kithsiri, et al.. (2021). Structure–Activity Relationships of Withanolides as Antiproliferative Agents for Multiple Myeloma: Comparison of Activity in 2D Models and a 3D Coculture Model. Journal of Natural Products. 84(8). 2321–2335. 8 indexed citations
6.
Berndt, Sarah, Mark E. Issa, Gilles Carpentier, & Muriel Cuendet. (2018). A Bivalent Role of Genistein in Sprouting Angiogenesis. Planta Medica. 84(09/10). 653–661. 13 indexed citations
7.
Goralski, Kerry B., Derek J. Roberts, Mark E. Issa, et al.. (2017). An observational study examining the effects of a surgically induced inflammatory response on the distribution of morphine and its metabolites into cerebrospinal fluid. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 64(10). 1009–1022. 3 indexed citations
8.
Issa, Mark E., et al.. (2017). Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma. Clinical Epigenetics. 9(1). 17–17. 65 indexed citations
9.
Issa, Mark E., E. M. Kithsiri Wijeratne, A. A. Leslie Gunatilaka, & Muriel Cuendet. (2017). Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma Cells. Frontiers in Pharmacology. 8. 610–610. 19 indexed citations
10.
Zwick, Vincent, Cláudia A. Simões‐Pires, Alessandra Nurisso, et al.. (2017). Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6. ACS Omega. 2(4). 1550–1562. 22 indexed citations
11.
Issa, Mark E., Sylvian Cretton, & Muriel Cuendet. (2017). Targeting Multiple Myeloma Cancer Stem Cells with Natural Products – Lessons from Other Hematological Malignancies. Planta Medica. 83(9). 752–760. 10 indexed citations
12.
Issa, Mark E., Sarah Berndt, Gilles Carpentier, John M. Pezzuto, & Muriel Cuendet. (2016). Bruceantin inhibits multiple myeloma cancer stem cell proliferation. Cancer Biology & Therapy. 17(9). 966–975. 30 indexed citations
13.
Issa, Mark E. & Muriel Cuendet. (2016). Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cells. MedChemComm. 8(1). 112–121. 18 indexed citations
14.
Issa, Mark E., et al.. (2015). Cytotoxic flavonoids and other constituents from the stem bark ofOchna schweinfurthiana. Natural Product Research. 29(17). 1684–1687. 32 indexed citations
15.
Issa, Mark E., et al.. (2013). Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells. Anti-Cancer Drugs. 25(3). 255–269. 30 indexed citations
16.
Issa, Mark E., Shanmugam Muruganandan, Matthew C. Ernst, et al.. (2012). Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis. American Journal of Physiology-Cell Physiology. 302(11). C1621–C1631. 34 indexed citations
17.
Ernst, Matthew C., Mark E. Issa, Kerry B. Goralski, & Christopher J. Sinal. (2010). Chemerin Exacerbates Glucose Intolerance in Mouse Models of Obesity and Diabetes. Endocrinology. 151(5). 1998–2007. 217 indexed citations
18.
Parlee, Sebastian D., et al.. (2008). Characterization of the Expression and Function of Chemerin and CMKLR1 within the Central Nervous System. The FASEB Journal. 22(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaowei Ma Breakdown of academic impact, for papers by Tian Shen Breakdown of academic impact, for papers by Lingling Xuan Breakdown of academic impact, for papers by Alexander T. Sougiannis Breakdown of academic impact, for papers by Areej Al-Roub Breakdown of academic impact, for papers by Jung Hwan Yu Breakdown of academic impact, for papers by Zhiyuan Chen Breakdown of academic impact, for papers by Eun Suk Ha Breakdown of academic impact, for papers by Shenglong Zhu Breakdown of academic impact, for papers by Samira Asghari
Rankless by CCL
2026